Cellverse Selected Among Top 5 Indian Startups for a Direct Audience with PM Modi and President Macron at VivaTech 2026
Two heads of state. One Indian founder. One conversation about the future of drug discovery.
Two heads of state. One Indian founder. One conversation about the future of drug discovery.
This week, Dr. Kanika Singroha presented Cellverse's work directly to Prime Minister Narendra Modi and French President Emmanuel Macron. She explained why human disease models based on realtime pathology assessment are most crucial for scientific drug discovery, drawing President Macron's interest toward Cellverse's patented AI digital twin model of Oral Cancer.
Out of 80+ startups under DPIIT's Startup India showcase, Cellverse was among just five selected for a direct audience with both leaders. The conversation wasn't a pitch. It was a serious discussion about where biology, AI, and precision medicine are heading — and what role Indian innovation can play in getting there.
Key Highlights & Takeaways
- ✓One of only 5 Indian startups selected out of 80+ DPIIT Startup India showcase to meet the leaders directly.
- ✓Presented advanced AI-driven Digital-Twin-Based In-Vitro Disease Models directly to Prime Minister Narendra Modi and French President Emmanuel Macron.
- ✓Explained why human disease models based on realtime pathology assessment are most crucial for scientific drug discovery.
- ✓Drew President Macron's interest specifically toward Cellverse's patented AI digital twin model of Oral Cancer.
“Dr. Kanika Singroha explained why human disease models based on realtime pathology assessment are most crucial for scientific drug discovery, drawing President Macron's interest toward Cellverse's patented AI digital twin model of Oral Cancer.”
Collaborators & Tags
Prime Minister Narendra Modi · President Emmanuel Macron · Dr. Kanika Singroha · DPIIT · Startup India · VivaTech 2026